1 min read
Add as a preferred source on GoogleNautilus Biotechnology, Inc. to Report Q3 Results Before Market Open Oct. 27
The consensus estimate calls for a loss of $0.14 per share and $210,000 in revenue.
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) is scheduled to announce third-quarter results before market open Tuesday, Oct. 27. The consensus estimate calls for a loss of $0.14 per share and revenue of $210,000.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.